Literature DB >> 25384457

Flow dependence of specific airway resistance and diagnostic of asthma in children.

Laurianne Coutier1, Iulia Ioan1, Ayria Sadegh-Eghbali1, Claude Bonabel1, Bruno Demoulin2, Thanh Le Tuan2, François Marchal1,2, Cyril Schweitzer1,2, Silvia Varechova1,2.   

Abstract

Panting majors turbulent flow and contribution of larger airways to the measurement of specific airway resistance (sRaw). The hypothesis was tested that the difference between asthmatic and healthy children is enhanced by narrowing the flow interval to compute sRaw. sRaw was measured during panting in 40 asthmatic and 25 healthy children and computed using all data points (full scale flow) and limited to the flow intervals ± 1L/sec and ± 0.5 L/sec. sRaw was not different between asthmatics (0.87 ± 0.20 kPa.s) and controls (0.80 ± 0.25 kPa.s) when computed full scale, while it was significantly larger in asthmatics than controls within ± 1L/sec (0.77 ± 0.16 kPa.s vs 0.65 ± 0.15 kPa.s, P < 0.004) or ± 0.5 L/sec (0.77 ± 0.21 kPa.s vs 0.61 ± 0.17 kPa.s, P < 0.002). On the other hand, the within subject coefficient of variation was significantly larger when sRaw was computed within ± 1L/sec (13.7 ± 7.2%) or ± 0.5 L/sec (28.3 ± 18.1%) than full scale (11.0 ± 6.7%), respectively P < 0.002 and P < 0.0001. It is concluded that narrowing the flow interval to compute sRaw is associated with better discrimination between asthma and health in children, although the short term variability of sRaw is increased.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  asthma; healthy; laminar airflow; panting; plethysmography; thermal effect; tidal breathing; turbulent airflow

Mesh:

Year:  2014        PMID: 25384457     DOI: 10.1002/ppul.23127

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  1 in total

1.  A Calibration Device to Compare Body Plethysmographs Among Pediatric Lung Function Laboratories.

Authors:  Bruno Demoulin; Iulia Ioan; Claude Duvivier; Claude Bonabel; Cyril Schweitzer; François Marchal; Silvia Demoulin-Alexikova
Journal:  Front Physiol       Date:  2018-10-09       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.